176 related articles for article (PubMed ID: 26320870)
1. A Comprehensive Strategy for Accurate Mutation Detection of the Highly Homologous PMS2.
Li J; Dai H; Feng Y; Tang J; Chen S; Tian X; Gorman E; Schmitt ES; Hansen TA; Wang J; Plon SE; Zhang VW; Wong LJ
J Mol Diagn; 2015 Sep; 17(5):545-53. PubMed ID: 26320870
[TBL] [Abstract][Full Text] [Related]
2. High incidence of large deletions in the PMS2 gene in Spanish Lynch syndrome families.
Brea-Fernández AJ; Cameselle-Teijeiro JM; Alenda C; Fernández-Rozadilla C; Cubiella J; Clofent J; Reñé JM; Anido U; Milá M; Balaguer F; Castells A; Castellvi-Bel S; Jover R; Carracedo A; Ruiz-Ponte C
Clin Genet; 2014 Jun; 85(6):583-8. PubMed ID: 23837913
[TBL] [Abstract][Full Text] [Related]
3. Avoidance of pseudogene interference in the detection of 3' deletions in PMS2.
Vaughn CP; Hart KJ; Samowitz WS; Swensen JJ
Hum Mutat; 2011 Sep; 32(9):1063-71. PubMed ID: 21618646
[TBL] [Abstract][Full Text] [Related]
4. Long-range PCR facilitates the identification of PMS2-specific mutations.
Clendenning M; Hampel H; LaJeunesse J; Lindblom A; Lockman J; Nilbert M; Senter L; Sotamaa K; de la Chapelle A
Hum Mutat; 2006 May; 27(5):490-5. PubMed ID: 16619239
[TBL] [Abstract][Full Text] [Related]
5. Quantification of sequence exchange events between PMS2 and PMS2CL provides a basis for improved mutation scanning of Lynch syndrome patients.
van der Klift HM; Tops CM; Bik EC; Boogaard MW; Borgstein AM; Hansson KB; Ausems MG; Gomez Garcia E; Green A; Hes FJ; Izatt L; van Hest LP; Alonso AM; Vriends AH; Wagner A; van Zelst-Stams WA; Vasen HF; Morreau H; Devilee P; Wijnen JT
Hum Mutat; 2010 May; 31(5):578-87. PubMed ID: 20186688
[TBL] [Abstract][Full Text] [Related]
6. Clinical analysis of PMS2: mutation detection and avoidance of pseudogenes.
Vaughn CP; Robles J; Swensen JJ; Miller CE; Lyon E; Mao R; Bayrak-Toydemir P; Samowitz WS
Hum Mutat; 2010 May; 31(5):588-93. PubMed ID: 20205264
[TBL] [Abstract][Full Text] [Related]
7. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.
Senter L; Clendenning M; Sotamaa K; Hampel H; Green J; Potter JD; Lindblom A; Lagerstedt K; Thibodeau SN; Lindor NM; Young J; Winship I; Dowty JG; White DM; Hopper JL; Baglietto L; Jenkins MA; de la Chapelle A
Gastroenterology; 2008 Aug; 135(2):419-28. PubMed ID: 18602922
[TBL] [Abstract][Full Text] [Related]
8. The frequency of previously undetectable deletions involving 3' Exons of the PMS2 gene.
Vaughn CP; Baker CL; Samowitz WS; Swensen JJ
Genes Chromosomes Cancer; 2013 Jan; 52(1):107-12. PubMed ID: 23012243
[TBL] [Abstract][Full Text] [Related]
9. Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants.
Borràs E; Pineda M; Cadiñanos J; Del Valle J; Brieger A; Hinrichsen I; Cabanillas R; Navarro M; Brunet J; Sanjuan X; Musulen E; van der Klift H; Lázaro C; Plotz G; Blanco I; Capellá G
J Med Genet; 2013 Aug; 50(8):552-63. PubMed ID: 23709753
[TBL] [Abstract][Full Text] [Related]
10. PMS2 involvement in patients suspected of Lynch syndrome.
Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
[TBL] [Abstract][Full Text] [Related]
11. Improved multiplex ligation-dependent probe amplification analysis identifies a deleterious PMS2 allele generated by recombination with crossover between PMS2 and PMS2CL.
Wernstedt A; Valtorta E; Armelao F; Togni R; Girlando S; Baudis M; Heinimann K; Messiaen L; Staehli N; Zschocke J; Marra G; Wimmer K
Genes Chromosomes Cancer; 2012 Sep; 51(9):819-31. PubMed ID: 22585707
[TBL] [Abstract][Full Text] [Related]
12. A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome.
Clendenning M; Senter L; Hampel H; Robinson KL; Sun S; Buchanan D; Walsh MD; Nilbert M; Green J; Potter J; Lindblom A; de la Chapelle A
J Med Genet; 2008 Jun; 45(6):340-5. PubMed ID: 18178629
[TBL] [Abstract][Full Text] [Related]
13. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
[TBL] [Abstract][Full Text] [Related]
14. PMS2 gene mutational analysis: direct cDNA sequencing to circumvent pseudogene interference.
Wimmer K; Wernstedt A
Methods Mol Biol; 2014; 1167():289-302. PubMed ID: 24823786
[TBL] [Abstract][Full Text] [Related]
15. A case of early onset rectal cancer of Lynch syndrome with a novel deleterious PMS2 mutation.
Nomura S; Fujimoto Y; Yamamoto N; Sato Y; Ashihara Y; Kita M; Yamaguchi J; Ishikawa Y; Ueno M; Arai M
Jpn J Clin Oncol; 2015 Oct; 45(10):987-92. PubMed ID: 26232782
[TBL] [Abstract][Full Text] [Related]
16. RNA-based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference.
Etzler J; Peyrl A; Zatkova A; Schildhaus HU; Ficek A; Merkelbach-Bruse S; Kratz CP; Attarbaschi A; Hainfellner JA; Yao S; Messiaen L; Slavc I; Wimmer K
Hum Mutat; 2008 Feb; 29(2):299-305. PubMed ID: 18030674
[TBL] [Abstract][Full Text] [Related]
17. Detecting clinically actionable variants in the 3' exons of PMS2 via a reflex workflow based on equivalent hybrid capture of the gene and its pseudogene.
Gould GM; Grauman PV; Theilmann MR; Spurka L; Wang IE; Melroy LM; Chin RG; Hite DH; Chu CS; Maguire JR; Hogan GJ; Muzzey D
BMC Med Genet; 2018 Sep; 19(1):176. PubMed ID: 30268105
[TBL] [Abstract][Full Text] [Related]
18. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.
ten Broeke SW; Brohet RM; Tops CM; van der Klift HM; Velthuizen ME; Bernstein I; Capellá Munar G; Gomez Garcia E; Hoogerbrugge N; Letteboer TG; Menko FH; Lindblom A; Mensenkamp AR; Moller P; van Os TA; Rahner N; Redeker BJ; Sijmons RH; Spruijt L; Suerink M; Vos YJ; Wagner A; Hes FJ; Vasen HF; Nielsen M; Wijnen JT
J Clin Oncol; 2015 Feb; 33(4):319-25. PubMed ID: 25512458
[TBL] [Abstract][Full Text] [Related]
19. Insertion of an SVA element, a nonautonomous retrotransposon, in PMS2 intron 7 as a novel cause of Lynch syndrome.
van der Klift HM; Tops CM; Hes FJ; Devilee P; Wijnen JT
Hum Mutat; 2012 Jul; 33(7):1051-5. PubMed ID: 22461402
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
